AMPRION

San Francisco, United States

Amprion is a biotech company that focuses on the diagnosis for brain diseases.

$6.0M raised

Sep 2024

Series B

Top Investors

Eli LillyPropel(X)ALS NetworkFormation Venture Engineering

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AMPRION raised?

AMPRION has raised $6.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.

Who are AMPRION's investors?

AMPRION's investors include Eli Lilly, Propel(X), ALS Network, Formation Venture Engineering.

Where is AMPRION headquartered?

AMPRION is headquartered in San Francisco, United States.

What does AMPRION do?

Amprion is a biotech company that focuses on the diagnosis for brain diseases.

What stage is AMPRION at?

AMPRION is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 25, 2024.

MLA

"AMPRION — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/amprion. Accessed June 14, 2026.

APA

VCBacked. (2024). AMPRION — Funding & Investors. Retrieved June 14, 2026, from https://www.vcbacked.co/company/amprion

Wikipedia (cite web)

{{cite web |title=AMPRION — Funding & Investors |url=https://www.vcbacked.co/company/amprion |website=VCBacked |access-date=June 14, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 25, 2024.